Physician profile
Hershel R Patel
NPI 1801216072
$1,427.88
in general payments reported to CMS, 2019-2025
14 companies · $417 in 2025
The $417 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.76 · 2022: $290 · 2023: $234 · 2024: $413 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $235.47 | 2022-2025 | Vabysmo |
| Abbvie INC. | $231.18 | 2022-2025 | |
| Apellis Pharmaceuticals, INC. | $176.19 | 2024-2025 | Syfovre |
| Bausch & Lomb Americas INC. | $172.12 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $140.22 | 2022-2025 | Eylea, Eylea Hd |
| Sun Pharmaceutical Industries INC. | $125.00 | 2024 | |
| US Oncology Corporate, INC. | $122.53 | 2025 | |
| Astellas Pharma US INC | $77.36 | 2025 | Izervay |
| Johnson & Johnson Vision Care, INC. | $50.44 | 2021 | |
| Harrow Eye, LLC | $29.54 | 2025 | |
| Coherus Oncology, INC. | $28.55 | 2023 | |
| Novartis Pharmaceuticals Corporation | $23.32 | 2021 | |
| Alimera Sciences, INC. | $15.96 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hershel Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.